- Home
- NRIX vs ALRM Comparison
NRIX vs ALRM Comparison
Compare NRIX & ALRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRIX | ALRM |
|---|---|---|
| Founded | 2009 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.4B |
| IPO Year | 2020 | 2015 |
Fundamental Metrics
Financial Performance| Metric | NRIX | ALRM |
|---|---|---|
| Price | $23.17 | $53.46 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 3 |
| Target Price | $30.50 | ★ $56.67 |
| AVG Volume (30 Days) | ★ 1.9M | 575.6K |
| Earning Date | 04-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.42 |
| EPS | N/A | ★ 0.47 |
| Revenue | $76,987,000.00 | ★ $1,011,187,000.00 |
| Revenue This Year | N/A | $7.00 |
| Revenue Next Year | $48.05 | $4.53 |
| P/E Ratio | ★ N/A | $115.11 |
| Revenue Growth | ★ 99.31 | 7.59 |
| 52 Week Low | $8.20 | $41.49 |
| 52 Week High | $25.09 | $59.53 |
Technical Indicators
Market Signals| Indicator | NRIX | ALRM |
|---|---|---|
| Relative Strength Index (RSI) | 61.64 | 74.63 |
| Support Level | $14.63 | $50.60 |
| Resistance Level | $24.98 | $53.80 |
| Average True Range (ATR) | 1.25 | 1.49 |
| MACD | -0.23 | 0.44 |
| Stochastic Oscillator | 50.58 | 84.55 |
Price Performance
Historical ComparisonAbout NRIX Nurix Therapeutics Inc.
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
About ALRM Alarm.com Holdings Inc.
Alarm.com Holdings Inc has a cloud-based platform that offers an expansive suite of IoT solutions addressing world-wide opportunities in the residential, multi-family, small business and enterprise commercial markets. It has two reportable segments: Alarm.com & Other. The Alarm.com segment represents the cloud-based Software platforms for intelligently connected property & related solutions. The other segment is focused on researching, developing & offering residential & commercial automation solutions & energy management products & services in adjacent markets. The majority of revenue is from the Alarm.com segment. The platform allows home & business owners to secure their properties and automate & control an array of connected devices.